Zobrazeno 1 - 10
of 410
pro vyhledávání: '"Marc Vanderheyden"'
Autor:
Ana Moya, Clara L. Oeste, Monika Beles, Sofie Verstreken, Riet Dierckx, Ward Heggermont, Jozef Bartunek, Eline Bogaerts, Imke Masuy, Dries Hens, Dario Bertolone, Marc Vanderheyden
Publikováno v:
ESC Heart Failure, Vol 10, Iss 6, Pp 3483-3492 (2023)
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM), a progressive and fatal cardiomyopathy, is frequently misdiagnosed or entails diagnostic delays, hindering patients from timely treatment. This study aimed to generate a systematic frame
Externí odkaz:
https://doaj.org/article/c6ce75b94ab64243a968f0a0fd0a2328
Autor:
Monika Beles, Imke Masuy, Sofie Verstreken, Jozef Bartunek, Riet Dierckx, Ward Heggermont, Clara Oeste, Marieke De Boeck, Isabelle Fovel, Michael Maris, Zarha Vermeulen, Marc Vanderheyden
Publikováno v:
ESC Heart Failure, Vol 10, Iss 4, Pp 2269-2280 (2023)
Abstract Aims The Cardiovascular Outcomes Retrospective Data analysIS in Heart Failure (CORDIS‐HF) is a single‐centre retrospective study aimed to (i) clinically characterize a real‐world population with heart failure (HF) with reduced (HFrEF)
Externí odkaz:
https://doaj.org/article/53f916f006bb4a5c8bd0f067d27725ac
Autor:
Lucia Scisciola, Fatemeh Taktaz, Rosaria Anna Fontanella, Ada Pesapane, Surina, Vittoria Cataldo, Puja Ghosh, Martina Franzese, Armando Puocci, Pasquale Paolisso, Concetta Rafaniello, Raffaele Marfella, Maria Rosaria Rizzo, Emanuele Barbato, Marc Vanderheyden, Michelangela Barbieri
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Background Sodium-glucose co-transporters (SGLT) inhibitors (SGLT2i) showed many beneficial effects at the cardiovascular level. Several mechanisms of action have been identified. However, no data on their capability to act via epigenetic me
Externí odkaz:
https://doaj.org/article/379f93e58d6a46ef880aa2f3958db2e4
Autor:
Pasquale Paolisso, Amir Dagan, Emanuele Gallinoro, Cristina De Colle, Dario Tino Bertolone, Ana Moya, Martin Penicka, Ivan Degrieck, Marc Vanderheyden, Jozef Bartunek
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 699-704 (2023)
Abstract The inadequacy of medical therapies for heart failure with preserved ejection fraction (HFpEF) is driving the development of device‐based solutions targeting underlying pathophysiologic abnormalities. The maladaptive autonomic imbalance wi
Externí odkaz:
https://doaj.org/article/6d5a9bbce99743418d31d687f004229d
Autor:
Robert Herman, Marc Vanderheyden, Boris Vavrik, Monika Beles, Timotej Palus, Olivier Nelis, Marc Goethals, Sofie Verstreken, Riet Dierckx, Martin Penicka, Ward Heggermont, Jozef Bartunek
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 3575-3584 (2022)
Abstract Aims Risk stratification in patients with a new onset or worsened heart failure (HF) is essential for clinical decision making. We have utilized a novel approach to enrich patient level prognostication using longitudinally gathered data to d
Externí odkaz:
https://doaj.org/article/e6c6ec2df9da4be39b63f406a6786866
Autor:
Raffaele Marfella, Nunzia D’Onofrio, Gelsomina Mansueto, Vincenzo Grimaldi, Maria Consiglia Trotta, Celestino Sardu, Ferdinando Carlo Sasso, Lucia Scisciola, Cristiano Amarelli, Salvatore Esposito, Michele D’Amico, Paolo Golino, Marisa De Feo, Giuseppe Signoriello, Pasquale Paolisso, Emanuele Gallinoro, Marc Vanderheyden, Ciro Maiello, Maria Luisa Balestrieri, Emanuele Barbato, Claudio Napoli, Giuseppe Paolisso
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-14 (2022)
Abstract Background High glycated-hemoglobin (HbA1c) levels correlated with an elevated risk of adverse cardiovascular outcomes despite renin-angiotensin system (RAS) inhibition in type-2 diabetic (T2DM) patients with reduced ejection fraction. Using
Externí odkaz:
https://doaj.org/article/8205c69318ef4c8fa6ce7570319743ed
Autor:
Martin Kotrc, Jozef Bartunek, Jan Benes, Monika Beles, Marc Vanderheyden, Filip Casselman, Tomas Ondrus, Yujing Mo, Frank Van Praet, Martin Penicka
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2686-2694 (2022)
Abstract Aims Identification of heart failure (HF) patients with secondary mitral regurgitation (SMR) that benefit from mitral valve (MV) repair remains challenging. We have focused on the role of left ventricular global longitudinal strain (LV‐GLS
Externí odkaz:
https://doaj.org/article/db04efd39fed4df2876ca076db03421e
Autor:
Emma L. Robinson, Pietro Ameri, Leen Delrue, Marc Vanderheyden, Jozef Bartunek, Paola Altieri, Stephane Heymans, Ward A. Heggermont
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundAnthracycline-induced cardiotoxicity is a well-known serious clinical entity. However, detailed mechanistic insights on how short-term administration leads to late and long-lasting cardiotoxicity, are still largely undiscovered. We hypothes
Externí odkaz:
https://doaj.org/article/e102d1878e214670940c50ef20f1b115
Autor:
Pasquale Paolisso, Emanuele Gallinoro, Niya Mileva, Ana Moya, Davide Fabbricatore, Giuseppe Esposito, Cristina De Colle, Monika Beles, Jerrold Spapen, Ward Heggermont, Carlos Collet, Guy Van Camp, Marc Vanderheyden, Emanuele Barbato, Jozef Bartunek, Martin Penicka
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 373-384 (2022)
Abstract Aims Non‐invasive myocardial work (MW) is a validated index of left ventricular (LV) systolic performance, incorporating afterload and myocardial metabolism. The role of MW in predicting the first hospitalization for de novo heart failure
Externí odkaz:
https://doaj.org/article/05498995473748a4872e327f3f1b47b1
Autor:
Leen Delrue, Marc Vanderheyden, Monika Beles, Pasquale Paolisso, Giuseppe Di Gioia, Riet Dierckx, Sofie Verstreken, Marc Goethals, Ward Heggermont, Jozef Bartunek
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4780-4790 (2021)
Abstract Aims We investigated the prognostic relevance of serpin peptidase inhibitor, clade A member 3 (SERPINA3) in patients admitted with a de novo or worsened heart failure (HF). Methods and results In the first stage, 83 HF‐related left ventric
Externí odkaz:
https://doaj.org/article/2dd42a98df5e4d9dace59bc79f9d21dd